Ejection fraction reflects how well the heart pumps by measuring the proportion of blood expelled from the left ventricle with each contraction. Low values can signal heart failure or other serious cardiovascular conditions. Millions of patients live with undiagnosed low EF until their disease is advanced, in part because echocardiography — the standard method for measuring EF — requires specialized equipment that may not always be available. By enabling EF detection from routine ECGs, one of the most common and accessible tests in medicine, ECG-EF allows clinicians to flag high-risk patients earlier and at scale.

Developed by cardiac diagnostics company Carelog, ECG-EF is now available within Bunkerhill’s Carebricks platform, which enables health systems to create AI-powered workflows that both analyze patient data and automate next steps — from notifying care teams and routing referrals to streamlining prior authorization, automating registry submissions, and triggering actions in third-party platforms.